BGP Products Operations GmbH, a Viatris Company
Clinical trials sponsored by BGP Products Operations GmbH, a Viatris Company, explained in plain language.
Now part of
Viatris Inc.
VTRS
NASDAQ
Pharmaceutical manufacturing subsidiary of Viatris.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Real-World study tracks elidel use in asian kids with eczema Results expected Oct 2026 (estimated)